In addition, AhR activation promoted SARS-CoV-2 infection and replication, limited type I IFN signaling, and up-regulated the expression of ACE2, thus acting as a proviral factor [40,41] whose inhibition was suggested to be used as a therapeutic approach in COVID-19. The gene discussed is AHR; the disease is COVID-19.